FdaApplication
ANDA 212026
Identifiers
- fda_app_no: ANDA212026
Properties
| Property | Value |
|---|---|
| applicant_name | AMTA LABS LTD |
| application_type | ANDA |
| approval_date | 2020-01-06 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PROPRANOLOL HYDROCHLORIDE | PROPRANOLOL HYDROCHLORIDE | 80MG | CAPSULE, EXTENDED RELEASE;ORAL |
| PROPRANOLOL HYDROCHLORIDE | PROPRANOLOL HYDROCHLORIDE | 60MG | CAPSULE, EXTENDED RELEASE;ORAL |
| PROPRANOLOL HYDROCHLORIDE | PROPRANOLOL HYDROCHLORIDE | 120MG | CAPSULE, EXTENDED RELEASE;ORAL |
| PROPRANOLOL HYDROCHLORIDE | PROPRANOLOL HYDROCHLORIDE | 160MG | CAPSULE, EXTENDED RELEASE;ORAL |
4 products